SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

30 May 2023 Evaluate
The sales slipped to Rs. 1003.17 millions for the March 2023 quarter as against Rs. 1065.53 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 126.95  millions from Rs. 147.06 millions ,decline by -13.67%.Operating profit for the quarter ended March 2023 decreased to 177.98 millions as compared to 215.13 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1003.17 1065.53 -5.85 3796.36 4058.42 -6.46 3796.36 4058.42 -6.46
Other Income 48.19 51.60 -6.61 145.42 153.83 -5.47 145.42 153.83 -5.47
PBIDT 177.98 215.13 -17.27 589.34 948.56 -37.87 589.34 948.56 -37.87
Interest 0.17 3.01 -94.35 0.77 4.85 -84.12 0.77 4.85 -84.12
PBDT 177.81 212.12 -16.17 588.57 943.71 -37.63 588.57 943.71 -37.63
Depreciation 13.10 11.93 9.81 52.12 37.95 37.34 52.12 37.95 37.34
PBT 164.71 200.19 -17.72 536.45 905.76 -40.77 536.45 905.76 -40.77
TAX 37.76 53.13 -28.93 138.11 233.88 -40.95 138.11 233.88 -40.95
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 126.95 147.06 -13.67 398.34 671.88 -40.71 398.34 671.88 -40.71
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 17.74 20.19 -12.13 15.52 23.37 -33.58 15.52 23.37 -33.58

Amrutanjan Healthcar Share Price

566.90 23.75 (4.37%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×